Author Correction: DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets

Author Correction: DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets

Bibliographic Details
Main Authors:	Arwa Raies, Ewa Tulodziecka, James Stainer, Lawrence Middleton, Ryan S. Dhindsa, Pamela Hill, Ola Engkvist, Andrew R. Harper, Slavé Petrovski, Dimitrios Vitsios
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-07-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-023-05086-5

Similar Items

DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets
by: Arwa Raies, et al.
Published: (2022-11-01)

AI for drug design: From explicit rules to deep learning
by: Lewis Mervin, et al.
Published: (2022-12-01)

Computational prediction and interpretation of druggable proteins using a stacked ensemble-learning framework
by: Phasit Charoenkwan, et al.
Published: (2022-09-01)

Generation of conformational ensembles of small molecules via surrogate model-assisted molecular dynamics
by: Juan Viguera Diez, et al.
Published: (2024-01-01)

Reinvent 4: Modern AI–driven generative molecule design
by: Hannes H. Loeffler, et al.
Published: (2024-02-01)

Druggable targets for Parkinson’s disease: An overview
by: Biswas Mridul, et al.
Published: (2024-01-01)

DRUGGABLE MM THERAPEUTICS: PATHOGENETIC PATHWAYS
by: Enrique M Ocio
Published: (2022-04-01)

Druggable Transient Pockets in Protein Kinases
by: Koji Umezawa, et al.
Published: (2021-01-01)

Mitochondrial Potassium Channels as Druggable Targets
by: Antoni Wrzosek, et al.
Published: (2020-08-01)

RORγ Structural Plasticity and Druggability
by: Mian Huang, et al.
Published: (2020-07-01)

Druggable genetic targets in endometrial cancer✰,✰✰
by: Steven Lehrer, et al.
Published: (2022-01-01)

The druggable genome: Twenty years later
by: Chris J. Radoux, et al.
Published: (2022-09-01)

Correction: Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics.
by: Ayal B Gussow, et al.
Published: (2018-01-01)

Druggable genomic landscapes of high-grade gliomas
by: Paola Ghanem, et al.
Published: (2023-12-01)

Novel Biomarkers and Druggable Targets in Advanced Melanoma
by: Pier Francesco Ferrucci, et al.
Published: (2021-12-01)

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
by: Mohammad Almasri, et al.
Published: (2022-02-01)

Toxoplasmosis: Current and Emerging Parasite Druggable Targets
by: Rana El Hajj, et al.
Published: (2021-12-01)

Covalency-enabled Drug Discovery is Redefining Druggability
by: Jeffrey M. McKenna, et al.
Published: (2023-08-01)

Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy
by: Reeju Amatya, et al.
Published: (2023-07-01)

Plectasin: from evolution to truncation, expression, and better druggability
by: Xuan Li, et al.
Published: (2023-12-01)

Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects
by: Hao-Jui Weng, et al.
Published: (2022-07-01)

KRAS: A Druggable Target in Colon Cancer Patients
by: Francesca Negri, et al.
Published: (2022-04-01)

Illuminating the druggable genome through patent bioactivity data
by: Maria P. Magariños, et al.
Published: (2023-05-01)

A structural atlas of druggable sites on Nav channels
by: Zhangqiang Li, et al.
Published: (2024-12-01)

Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
by: Marina Pierrevelcin, et al.
Published: (2020-08-01)

Intestinal Enteroendocrine Cells: Present and Future Druggable Targets
by: Roger Atanga, et al.
Published: (2023-05-01)

Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
by: Samir Mouhssine, et al.
Published: (2022-09-01)

KEAP1/NRF2 as a druggable target
by: Dinkova-Kostova Albena T.
Published: (2023-01-01)

Druggable gene alterations in Japanese patients with rare malignancy
by: Akihiro Ohmoto, et al.
Published: (2022-11-01)

PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer
by: Camilla Albano, et al.
Published: (2024-03-01)

Glutathione facilitates enterovirus assembly by binding at a druggable pocket
by: Duyvesteyn, H, et al.
Published: (2020)

Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
by: Chow, Y.P., et al.
Published: (2017)

Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
by: Chow, Y.P., et al.
Published: (2017)

A druggable conformational switch in the c-MYC transactivation domain
by: Dilraj Lama, et al.
Published: (2024-02-01)

Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
by: Ludovico Pipitò, et al.
Published: (2022-12-01)

Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target
by: Sergio Enríquez-Flores, et al.
Published: (2020-07-01)

Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis
by: Wirawan Adikusuma, et al.
Published: (2022-01-01)

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis
by: Jieun Kim, et al.
Published: (2023-01-01)

A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas
by: Leonardo Delello Di Filippo, et al.
Published: (2023-06-01)

Basigin is a druggable target for host-oriented antimalarial interventions
by: Zenonos, Zenon A., et al.
Published: (2016)